- Home
- IMCR vs BORR Comparison
IMCR vs BORR Comparison
Compare IMCR & BORR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IMCR | BORR |
|---|---|---|
| Founded | 2008 | 2016 |
| Country | United Kingdom | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 2016 | 2017 |
Fundamental Metrics
Financial Performance| Metric | IMCR | BORR |
|---|---|---|
| Price | $28.59 | $6.13 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 2 |
| Target Price | ★ $66.33 | $6.25 |
| AVG Volume (30 Days) | 369.3K | ★ 7.4M |
| Earning Date | 05-07-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 30.39 | N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | ★ $249,428,000.00 | N/A |
| Revenue This Year | $14.57 | $5.80 |
| Revenue Next Year | $8.21 | $21.67 |
| P/E Ratio | $118.60 | ★ $20.64 |
| Revenue Growth | ★ 43.05 | N/A |
| 52 Week Low | $27.47 | $1.55 |
| 52 Week High | $40.71 | $6.33 |
Technical Indicators
Market Signals| Indicator | IMCR | BORR |
|---|---|---|
| Relative Strength Index (RSI) | 43.41 | 60.18 |
| Support Level | $28.90 | $5.25 |
| Resistance Level | $34.35 | $6.26 |
| Average True Range (ATR) | 1.31 | 0.27 |
| MACD | 0.11 | 0.01 |
| Stochastic Oscillator | 35.41 | 78.19 |
Price Performance
Historical ComparisonAbout IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
About BORR Borr Drilling Limited
Borr Drilling Ltd is a drilling contractor that owns and operates jack-up rigs of modern and high-specification designs providing drilling services to the oil and gas exploration and production industry. The company operates a fleet of around 16 jack-up drilling rigs. Geographically the activities are carried out through Norway.